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The Notch signaling pathway plays an essential role in the
regulation of cell specification by controlling differentiation,
proliferation, and apoptosis. Numb is an intrinsic regulator of
the Notch pathway and exists in four alternative splice variants
that differ in the length of their phosphotyrosine-binding
domain (PTB) and proline-rich region domains. The physiolog-
ical relevance of the existence of the Numb splice variants and
their exact regulation are still poorly understood.Wepreviously
reported that Numb switches from isoforms containing the
insertion in PTB to isoforms lacking this insertion in neuronal
cells subjected to trophic factor withdrawal (TFW). The func-
tional relevance of the TFW-induced switch in Numb isoforms
is not known. Here we provide evidence that the TFW-induced
switch inNumb isoforms regulatesNotch signaling strength and
Notch target gene expression. PC12 cells stably overexpressing
Numb isoforms lacking thePTB insertion exhibitedhigher basal
Notch activity and Notch-dependent transcription of the tran-
sient receptor potential channel 6 (TRPC6) when compared
with those overexpressing Numb isoforms with the PTB inser-
tion. The differential regulation of TRPC6 expression is corre-
lated with perturbed calcium signaling and increased neuronal
vulnerability to TFW-induced death. Pharmacological inhibi-
tion of the Notch pathway or knockdown of TRPC6 function
ameliorates the adverse effects caused by the TFW-induced
switch in Numb isoforms. Taken together, our results indicate
that Notch and Numb interaction may influence the sensitivity
of neuronal cells to injurious stimuli bymodulating calcium-de-
pendent apoptotic signaling cascades.
The Notch pathway is required for the embryonic and post-
natal development of many organs by regulating cell prolifera-
tion, differentiation, and apoptosis through direct cell to cell
contact (1). Notch consists of a family of single-pass transmem-
brane receptors (Notch1–4), which can be activated by inter-
action with membrane-tethered ligands of the Delta/Serrate/
Lag2 family expressed on neighboring cells (2). Upon
activation, Notch is cleaved by -secretase (3), releasing from
the membrane the Notch intracellular domain (NICD)3 that
translocates to the nucleus.NICDassociateswithCSL (an acro-
nym for themammalianCBF-1,Drosophila Suppressor ofHair-
less andCaenorhabditis elegans Lag-1 transcription factors (4))
to control the expression of target genes,most notably the basic
helix-loop-helix transcription factors belonging to the Hes
(hairy and enhancer of split) (5) andHerp (Hes-related protein)
family (6). These transcription factors in turn regulate the abil-
ity of the cells to respond to environmental clues. In the absence
of Notch signaling, CSL represses transcription of Notch target
genes, and following activation byNotch, CSL is converted into
a transcriptional activator and activates transcription of the
same genes (7). Disruption of the Notch gene in mice results in
severe developmental defects and embryonic lethality, support-
ing a major role for Notch in regulating cell fate (8).
Alterations in Notch signaling are associated with tumori-
genesis suggesting that dysfunction of intracellular Notch pre-
vents differentiation, ultimately guiding undifferentiated cells
toward malignant transformation (9, 10). One key regulator of
Notch signaling is Numb, an evolutionarily conserved adapter
protein identified by its ability to control cell fate in the nervous
system of Drosophila (11). Loss of Numb expression has been
shown to promote tumorigenesis (12) suggesting that the func-
tion of Numb is important for limiting signaling through the
Notch pathway. Numb is lost in 50% of human breast carci-
noma samples, and its level is inversely correlated with grade
and proliferation rate (12). Numb contains two protein-protein
interaction domains, a phosphotyrosine-binding (PTB) domain
and a proline-rich region (PRR) (13).Whereas only one form of
Numb has been identified in Drosophila, mammals produce
fourNumb isoforms that differ in the length of the PTB (lacking
or containing an 11-amino acid insert) and PRR (lacking or
containing a 48-amino acid insert) domains (13, 14).
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Emerging evidence supports the notion that the Numb iso-
forms are functionally significant and have different biologic
effects (13–16). In the mouse P19 embryonic carcinoma cell
line, it was shown that expression of Numb isoforms with short
PRR promote differentiation but not proliferation, whereas
expression of Numb isoforms with long PRR promote prolifer-
ation but not differentiation (15). Expression ofNumb isoforms
that lack the insertion in the PTB (short PTB or SPTB) but not
thosewith the insertion (long PTBor LPTB) increases neuronal
vulnerability to apoptotic insults through a mechanism that
involves perturbation of calcium (Ca2) homeostasis (16).
The intracellular messenger Ca2 controls a vast array of
cellular functions ranging from short term responses, such as
motility and secretion, to longer term control of gene expres-
sion, cell division, and various metabolic reactions (17).
Another major role for Ca2 is in cell death in physiological
settings or during injury or diseases (18–21, 49). The mecha-
nisms that control cellular Ca2 dynamics are complex, with
ion channels and pumps in the plasma membrane and endo-
plasmic reticulum (ER) playing major roles in regulating both
rapid and long term changes in the cytoplasmic free Ca2 con-
centration ([Ca2]i). Ca2 entry is controlled by voltage-gated
and ligand-gated channels, store-operated channels (SOCs),
and receptor-operated channels (ROCs). The latter are classi-
fied according to the initial stimulus for channel activation.
Whereas SOCs are recruited in response to the release of Ca2
from intracellular stores (22, 23), ROCs are activated by G-pro-
tein-coupled receptors (24). Although the exactmolecular con-
figuration of SOCs and ROCs has not been conclusively identi-
fied, much attention has been focused on the role of canonical
transient receptor potential channel (TRPC) subfamily in this
process (25). The TRPC subfamily of proteins consists of seven
mammalian TRPC isoforms numbered from 1 to 7 and is
expressed in a variety of tissues, with surprisingly high levels of
expression seen in the brain and heart (26). Functional studies
showed that they form voltage-independent cationic channels
with distinct gating and biophysical properties when heteroge-
neously expressed in various cell lines (26). Among the TRPC
members, TRPC6 has been linked to diverse cellular functions,
and its aberrant expression has been associated with various
disease states such as cardiac hypertrophy, pulmonary hyper-
tension, and glomerulosclerosis (27–29).
In the present study we found that the switch of Numb iso-
forms increases neuronal vulnerability to TFW-induced death
by a mechanism that involves Notch-dependent transcription
of TRPC6. Our results may have important implications for the
development of therapeutic modalities to counteract perturba-
tions of Ca2 signaling in various disease states.
EXPERIMENTAL PROCEDURES
Reagents—Antibodies used for immunodetection of Notch
and NICD were anti- Notch1 (G-20, Santa Cruz Biotechnol-
ogy) and Val-177 anti-NICD (Upstate), respectively. The poly-
clonal antibodies to Numb were obtained from Santa Cruz (sc-
15590) and Upstate (anti-pan-Numb). The antibodies to
TRPC1–7 were kindly provided by Dr. Schilling (CaseWestern
University). Additional antibodies included: anti-Rab5 (Santa
Cruz Biotechnology) and actin (Sigma). Immunofluorescence-
conjugated secondary antibodies (Alexa Fluor 488-conjugated
goat anti-mouse and Alexa Fluor 594-conjugated rabbit anti-
goat IgG) were obtained from Vector Laboratories (Burl-
ingame, CA). All commercial antibodies were used within the
concentration ranges recommended by the manufacturer.
Additional reagents included: Lipofectamine 2000, TRIzol, and
Opti-MEM I-reducedmedium (Invitrogen); DAPT (N-[N-(3,5-
difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester)
and -Secretase Inhibitor II (Calbiochem); oleoyl-2-acetyl-sn-
glycerol (OAG), carbachol, cyclopiazonic acid, and thapsigar-
gin (Sigma); SKF96365 and nifedipine (Tocris); ECL-Plus kit
(Amersham Biosciences); propidium iodide, Hoechst, and
Fura-2AM (Molecular Probes); and a -secretase fluorometric
(EDANS/DABCYL) assay kit (R&D Systems).
Plasmid Constructs, Transfection, and Generation of Stably
Transfected Cells—The pcDNA3.1 constructs for all four
human Numb isoforms have been described previously (30).
Pheochromocytoma 12 (PC12) cells were transfected with the
expression vector pcDNA3.1 with or without cDNAs for each
of the human Numb isoforms. Stably expressing clones were
selected withG418 andmaintained as previously described (30,
31). Cultures weremaintained at 37 °C (5%CO2 atmosphere) in
RPMI medium supplemented with 10% heat-inactivated horse
serum, 5% heat-inactivated fetal bovine serum, antibiotic, and
0.5 mg/ml G418.
Experimental Treatments—Trophic factor withdrawal
(TFW) was accomplished by washing cultures four times (2 ml
per wash) with Locke’s buffer (154 mM NaCl, 5.6 mM KCl, 2.3
mM CaCl2, 1.0 mMMgCl2, 3.6 mMNaHCO3, 5 mM glucose, and
5 mM HEPES, pH 7.2) with subsequent incubation in 1 ml of
Locke’s buffer (30, 31). DAPT and FK506 were dissolved in
DMSO and used to inhibit -secretase and calcineurin activity,
respectively. Control cultures were treated with equivalent vol-
umes of DMSO.
Quantification of Cell Death—Cell viability was assessed
using the fluorescent DNA binding dye Hoechst 33342 as
described previously (32). Briefly, after treatment, cells were
stained for 15 min at 37 °C with 2 M propidium iodide and 5
g/ml Hoechst dye in PBS. Cells were washed twice with PBS
and fixed with 4% paraformaldehyde for 1 h at room tempera-
ture. Coverslips were mounted at microscope slides using DPX
mounting medium for histology (Fluka) and visualized under a
fluorescence microscope (Zeiss). Fluorescent images of three
random fields per coverslip were acquired, and morphologi-
cally distinct apoptotic cells with condensed nuclei were
counted. The data from three independent experiments were
statistically examined by paired t test and are expressed as
means S.E. Cellswere counted, and the percent cell deathwas
assessed using a ratio of propidium iodide-stained cells to total
number of cells.
siRNA Constructs and Transfection—Stably transfected
PC12 cells were cultured as described above to 50–70% conflu-
ency. TRPC3 and TRPC6 were knocked down using Stealth
siRNA (Invitrogen): TRPC3, UCAUCUUCCUGGGUCUGCU-
UUGUGUU andTRPC6, AACAUUCCAAAGUCAAGCAUA-
UUCC.A Stealth RNAiNegative duplexwith limited homology
to any known sequences in human, mouse, and rat genomes
was used as control (Invitrogen). Notch siRNA consisting of a
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pool of three to five target-specific sequences was obtained
from Santa Cruz Biotechnology. Cells were transfected with
100 nM siRNA using Lipofectamine 2000 in Opti-MEM I-re-
duced medium for 24–48 h and then subjected to the experi-
mental treatments described above.
Ca2 Imaging—Real-time fluorescence measurements of
intracellular Ca2 concentration ([Ca2]i) were performed as
described previously (16). Briefly, cells were incubated for 10
min in the presence of 2.5 m of the acetoxymethylester form
of fura-2 (Molecular Probes) at 37 °C, washed three times with
serum-free RPMI. Coverslips containing cells were mounted in
a closed, heated chamber on the stage of an inverted micro-
scope (Nikon TSE 100 Eclipse). Cells were superfused with
Krebs Ringer bicarbonate (KRB) solution containing (in mM):
118 NaCl, 4.7 KCl, 0.57MgSO4, 1.18 KH2PO4, 25 NaHCO3, 2.5
CaCl2, and 10 glucose. Cells were perfused for 15 min prior to
beginning experiments to remove extracellular dye. Ratiomet-
ric measurement of fura-2 fluorescence was performed using a
collimated light beam from a xenon arc lamp filtered at 340 and
380 nm and focused onto Cells via a 20 fluorescence objective
(Super Fluor 20, Nikon). The fluorescence was collected from
30–50 cells simultaneouslymonitored. Only one field was used
per dish. Protocols were executed, and data were collected on-
line with InCyte software (Intracellular Imaging Inc.). Back-
ground fluorescence signals were collected at the same rate for
the same wavelengths and were subtracted from the corre-
sponding fluorescence images. In some experiments Ca2 was
omitted from theKRBbufferwithout (Ca2-deficient buffer) or
with 100 M EGTA (Ca2-free buffer). SOCE was induced by
stimulation with thapsigargin (TG, 1 M) as described previ-
ously (33, 34). Measurements were taken until [Ca2]i reached
resting level. Cells were then superfused with 2 mM Ca2-con-
taining KRB. Measurements were continued for 2–4 min after
Ca2 peak was recorded. In most instances, fluorescence ratios
(fluorescence at 510 nm with excitation at 340 nm divided by
that with excitation at 380) were reported.
Total RNA Isolation and Real-time PCR—Total RNA was
extracted using the TRIzol reagent according to the manufac-
turer’s recommendation, and 1 g of total extracted RNA was
used for synthesis of first-strand cDNAusing SuperScriptTM III
RNase H reverse transcriptase and 1 g of oligo(dT). Succes-
sively, 2 l of each cDNAwas PCR-amplified on the ABI Prism
7700 sequence detection system by using SYBR Green PCR
core reagents and 300 nM primers in a 25-l reaction volume.
PCR primers for the TRPC homologs were designed based on
published sequences in GenBankTM (Table 1). The integrity of
the RT-PCR products was confirmed bymelting curve analysis.
Melting curves for all TRPCs showed one specific peak. We
used 18 S mRNA as an endogenous control to normalize vari-
ations in RNA extraction, the degree of RNA degradation, and
variability in RT efficiency. We quantified the results with the
comparative Ct method (35).
SDS-PAGE and Western Blotting—Cells were harvested and
lysed in buffer (100 mM Tris, pH 6.8, 1% SDS, 10 mM EDTA, 5
mM EGTA, 2 mM phenylmethylsulfonyl fluoride, 25 g/ml leu-
peptin, 5 g/ml pepstatin). Protein quantification, electro-
phoretic separation, and transfer to nitrocellulose membranes
were performed as described previously (33). Membranes were
incubated in blocking solution (5%milk inTweenTris-buffered
saline (TTBS)) overnight at 4 °C followed by a 1-h incubation in
primary antibody diluted in blocking solution at room temper-
ature. Membranes were then incubated for 1 h in secondary
antibody conjugated to horseradish peroxidase (Vector Labo-
ratories), and bands were visualized using a chemilumines-
cence detection kit (ECL,AmershamBiosciences). The primary
antibodies included rabbit polyclonal antibodies against
TRPC3 and TRPC6. Membranes were stripped and re-probed
with the actin antibody to verify and normalize protein loading
(50 g of total protein, unless stated otherwise).
For immunodetection of blots, enhanced chemilumines-
cence was applied. The intensity of the signals obtained was
evaluated by densitometry and semiquantified using
National Institutes of Health Image software based on the
ratio between the intensity of the protein of interest divided
by the intensity of actin in each experiment. Each experi-
ment presented was repeated at least three times using dif-
ferent cell lysates.
Immunofluorescence Labeling—Following experimental
treatments, cultured cells were fixed for 20 min with 4%
paraformaldehyde in PBS. Cells were then incubated for 5
min in a solution of 0.2% Triton X-100 in PBS and for 1 h in
blocking solution (0.02% Triton X-100, 5% normal horse or
goat serum in PBS). After nonspecific binding was blocked,
coverslips were incubated with a polyclonal antibody to
TRPC6 or a polyclonal Numb antibody (1:500) in combina-
tion with a monoclonal antibody to the organelle marker
Rab5 (early endosomes). All antibodies were diluted in
blocking solution. After three washes, coverslips were incu-
bated with fluorescein isothiocyanate-conjugated anti-rab-
bit and Cy3-conjugated anti-mouse secondary antibodies
and thenmounted. Immunofluorescence staining was exam-
ined by confocal microscopy (Zeiss) using the 63 oil
immersion objective lens, and images were processed by
using the imaging software.
-Secretase Activity Assay—The activity of -secretase in cell
extracts was determined using a commercially available secre-
tase kit according to the manufacturer’s protocol (R&D Sys-
tems). The method is based on the -secretase-dependent
cleavage of a specific peptide conjugated to the fluorescent
reporter molecules EDANS and DABCYL, which results in the
release of a fluorescent signal that can be detected using a fluo-
rescence microplate reader (excitation at 355 nm/emission at
510 nm). The level of -secretase enzymatic activity is propor-
tional to the fluorometric reaction (36).
Calcineurin Activity Assay—Cellular calcineurin phospha-
tase activity was measured using a commercial non-radioactive
Calcineurin Cellular Activity Assay Kit, according to the man-
ufacturer’s instruction (Biomol). The RII phosphopeptide
(DLDVPIPGRFDRRVpSVAAE) derived from theRII subunit of
cAMP-dependent kinase, was used as the substrate for cal-
cineurin. PC12 cells were lysed in ice-cold lysis buffer and cen-
trifuged at 100,000 g for 45 min. After removal of free phos-
phate from the supernatant in the Desalting Column Resin, the
lysates were incubated with RII phosphopeptide (1.64 mg/ml)
in assay buffer containing 100 mM NaCl, 50 mM Tris-HCl (pH
7.5), 6 mM MgCl2, 0.5 mM dithiothreitol, 0.025% Nonidet P-40
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with 0.5mMCaCl2 or with 10mM EGTA. Purified recombinant
calcineurin was used as the positive control. After 30 min at
30 °C, reactions were terminated by adding 100 l of Biomol
GREENTM reagent, and absorbance was measured at A620 nm
using a 96-well plate reader (Bio-Rad). A standard curved was
plotted as A620 nm versus nanomoles of PO4 (used as the stand-
ard). Calcineurin activity was determined by subtracting the
EGTA-insensitive activity from total activity.
Statistical Analysis—Comparison between two groups was
performed using Student’s t test, whereas multiple compari-
sons between more than two groups was analyzed by one-way
ANOVA and post hoc tests by least significant difference. Data
evaluated for the effects of two variables was analyzed using two-
way ANOVA. Results are presented as means S.E. For all anal-
yses, statistical significance is defined as a p value of0.05.
RESULTS
TFW Activates the Notch Signal-
ing Pathway—To determine whether
the Notch pathway is activated in
response to TFW, we measured the
level of NICD, the activated form of
Notch (1), by immunoblotting with
the antibody Val-177, specific for
NICD. In untreated cultures of
PC12 cells, the NICD protein level
was low but was rapidly up-regu-
lated after TFW (Fig. 1A). Consist-
ent with activation of the Notch
pathway, the nuclear accumulation
of NICD (supplemental Fig. S1) and
the expression of the Notch down-
stream gene Hes1 (Fig. 1B) were
detected after TFW.To further con-
firm the involvement of the Notch
pathway in TFW-induced death,
we employed the small molecule
-secretase inhibitor DAPT to
pharmacologically inhibit the pro-
teolytic processing of Notch to
NICD (36). Notch pathway inhibi-
tionwas confirmed by immunoblot-
ting and immunostaining using an
antibody to NICD. Pre-treatment of
PC12 cells with DAPT strongly
reduced the amount of NICD,
although itwas not completely abol-
ished (Fig. 1C). Immunolabeling
indicated that pretreatment with
DAPT greatly abrogated TFW-in-
duced nuclear accumulation of
NICD (data not shown). No staining
was observed when the primary
antibody was omitted or when the
antibody was blocked (data not
shown). DAPT also substantially
inhibited Hes1 mRNA expression
after TFW (Fig. 1C), which confirms
the efficacy ofDAPT in inhibiting the
TFW-induced activation of the Notch pathway. To establish
that Notch1 is responsible for TFW-induced Notch signal-
ing, we inhibited Notch1 expression by RNA interference.
The effectiveness of silencing the expression of endogenous
Notch1 was determined by immunoblotting (Fig. 1D). Inhi-
bition of Notch1 substantially inhibited TFW-induced accu-
mulation of NICD (Fig. 1D), which confirms the findings
obtained with pharmacological inhibition of the Notch path-
way (Fig. 1C).
The TFW-induced Switch in Numb Isoform Is Reversible and
Precedes Transcriptional Activation of Notch-regulated Gene
Targets—We previously reported that TFW induces the switch
in Numb from isoforms containing the PTB insertion to iso-
forms lacking this insertion in PC12 cells (30, 31). To determine
FIGURE 1. TFW activates the Notch signaling pathway by inducing a switch in Numb isoforms. A, repre-
sentative immunoblot showing the timecourseofNICDprotein level in culturesof PC12cells subjected toTFW.
For each lane, 40 g of total protein extract was applied. Equal protein load was confirmed by reprobing the
blots for actin. The histogram shows the density of the NICD protein band normalized to actin. *, p  0.05
(ANOVA with Scheffe post-hoc tests) compared with untreated cells. B, time course of steady-state levels of
Hes1 transcript in PC12 cells after TFW. The level of Hes-1 transcript was determined in triplicate by real-time
PCR andwas normalized to the expression of housekeeping gene 18S. Values are themeans S.E. of determi-
nations made of three independent experiments. *, p 0.05 (ANOVA with Scheffe post-hoc tests) compared
with untreated cultures. C, representative immunoblot showing the time course of TFW-inducedNICDprotein
in cultures thatwere treatedwithDAPT (20M)or vehicle (DMSO). Thehistogram shows thedensityof theNICD
protein band normalized to actin. Values are the means S.E. of three independent experiments. *, p 0.05
(ANOVA with Scheffe post-hoc tests) compared with untreated cells at each time point. D, representative
immunoblot showing the time course of Notch1 and NICD in cultures that were transfected with a siRNA
targeting Notch1 (siRNA-Notch1) or non-silencing control siRNA (siRNA-Con). Each siRNA (100 nM) was added
to the cultures 24 h prior to TFW. At the indicated time points following TFW, total protein lysates were
analyzed by immunoblotting using an antibody to either the N-terminal region of Notch1 or NICD. Equal
protein loading was confirmed by reprobing the blots with an antibody to actin. Shown is the extracellular
domain of Notch1 (180 kDa). E, time course of steady-state levels of SPTB- and LPTB-Numb transcripts in
cultures of PC12 cells before andafter TFW. Levels of eachNumb transcriptsweredeterminedby real-timePCR,
normalized to the housekeeping gene 18S, and expressed in -fold change relative to the non-treated cultures.
Values are themeans S.E. of three independent experiments. *,p0.05 (ANOVAwith Scheffe post-hoc tests)
compared with untreated cultures.
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whether the Numb isoform switch preceded activation of the
Notch pathway, we quantitatively assessed transcripts levels of
the Numb proteins that differ in the PTB domain in PC12 cells
by RT-PCR using primer sets described previously (31). Time-
course study showed that the SPTB-Numb transcripts
increased rapidly and peaked at 8 h (Fig. 1E), suggesting that the
TFW-induced switch in Numb isoforms is an early event that
precedes the time point duringwhichNICD accumulates in the
nucleus (Fig. 1B) or before the appearance of the Hes1 tran-
script (Fig. 1C). The level of SPTB-Numb transcripts returned
to near basal level in cultures that had been subjected to TFW
for up to 6 h and then resupplied trophic support for an addi-
tional 2 h (supplemental Fig. S2) suggesting that TFW-induced
switch in Numb isoforms is reversible.
Numb-mediated Control of the Notch Signaling Pathway Is
PTBDomain-specific—The functions of theNumb proteins are
defined by their interaction with other cellular proteins via the
PTBdomain (37, 38). Although inhibition ofNotch signaling by
Numb is critical for many cell fate decisions (39, 40), it is not
clear whether all Numb isoforms demonstrate similar influence
on modulating the Notch signaling events.
To determine whether the Numb proteins modulate activa-
tion of the Notch pathway in an isoform-specific manner, we
measured protein level of NICD in PC12 clones stably overex-
pressing human Numb isoforms with long PTB and short PRR
(LPTB/SPRR) and short PTB and short PRR (SPTB/SPRR) (30,
31). PC12 clones overexpressing
SPTB-Numb (PC12-SPTB-Numb)
exhibited higher basal levels of
NICD compared with PC12-LPTB-
Numb or control vector-transfected
cells (PC12-VT) (Fig. 2A). By con-
trast, basal levels of NICD in PC12-
LPTB-Numbwere lower but did not
reach statistical significance when
compared with PC12-VT (Fig. 2A).
NICD was detected in the nuclei
of PC12-SPTB-Numb but not
PC12-VT and PC12-LPTB-Numb
(Fig. 2B). Hes-1 mRNA levels were
also highest in PC12-SPTB-Numb
(Fig. 2C) confirming that steady-
state Notch activity is elevated
in PC12-SPTB-Numb. Collectively,
the data indicate that the Numb
proteins that differ in the length of
the PTB domain affect the process-
ing of Notch in a distinct and con-
trasting manner.
PTB Domain-specific Control of
theNotch Pathway Is Independent of
-Secretase Activity or the Expres-
sion of Notch Pathway Genes—
Next, we determined the underlying
mechanism whereby the Numb
proteins differentially impact sig-
naling through the Notch pathway.
To exclude the possibility that the
Numb isoforms may alter the activity of the Notch processing
enzyme -secretase, we quantified -secretase activity in
lysates prepared from each stable PC12 clone (31). The activity
of -secretase was not affected by the presence of the different
Numb isoforms (Fig. 3A). To determine whether the Numb
isoforms may alter the expression of Notch pathway compo-
nents, we measured transcripts levels of Notch1 and its ligand
Jagged1 (41) in PC12 clones by qRT-PCR. Levels of Notch1 and
Jagged1 transcriptswere notmarkedly affected by expression of
the Numb isoforms (Fig. 3B). These data indicate that Numb-
mediated control of Notch signaling strength was not attribut-
able to changes in the expression of components of the Notch
pathway. Because the clones expressing the SPTB-Numb and
LPTB-Numb are phenotypically similar with respect to Notch
signaling, we performed forthcoming experiments with two
representative clones of Numb that differ only in the PTB
domain: SPTB/SPRR and LPTB/SPRR.
Numb Regulates Post-endocytic Sorting and Activation of
Notch in a Manner Dependent on the PTB Domain—Numb is
an adapter protein that interacts with components of the endo-
cyticmachinery (42) and plays roles in the endocytic trafficking
of several transmembrane proteins, including the neuronal cell
adhesion molecule L1 (43), E-cadherin (44), and amyloid pre-
cursor protein (APP) (31). Given that the Numb proteins dif-
ferentially impact the trafficking and processing fate of APP
(31) and that Notch is amembrane protein that undergoes sim-
FIGURE2.Numbmodulates theNotch signalingpathway in an isoform-specificmanner.A, representative
immunoblot of theNICDprotein in the PC12 clones stably overexpressing theNumb isoforms that differ in the
PTB domain. Equal protein load was confirmed by reprobing the blots for actin. The histogram shows the
density of the NICD protein band normalized to actin. The values are the means S.E. of three independent
experiments. *,p0.05 (ANOVAwithScheffepost-hoc tests) comparedwithuntreatedcells at each timepoint.
B, representative micrographs of NICD immunoreactivity in the nuclei of the indicated clones of PC12 cells.
Scale bars represent 15m. The histogram shows the average NICD immunoreactivity per nucleus. *, p 0.05
(ANOVA with Scheffe post-hoc tests) compared with PC12-VT cells. C, steady-state level of Hes-1 transcript in
the indicated PC12 clones. The level of Hes-1 transcript was determined in triplicate by real-time PCR and
normalized to the expression of the housekeeping gene 18S. The values are the means  S.E. of three inde-
pendent experiments. *, p 0.05 (ANOVA with Scheffe post-hoc tests).
Notch Regulates Ca2 Signaling
FEBRUARY 26, 2010•VOLUME 285•NUMBER 9 JOURNAL OF BIOLOGICAL CHEMISTRY 6815
ilar proteolytic processing as APP (45, 46), we next tested the
hypothesis whether the Numb proteins may also regulate the
trafficking of theNotch receptor within the endocytic pathway.
Rab5A is a small GTPase localized on early endosomes and
controls endosome fusion along the endocytic pathway.Double
immunofluorescence labeling showed that the Notch protein
co-localized with Rab5-labeled early endocytic compartments
in PC12-SPTB-Numb (Fig. 3C). By contrast, PC12-VT and
PC12-LPTB-Numb exhibited little or undetectable co-labeling
ofNotchwith the Rab5 proteinmarker (Fig. 3C). These data are
consistent with the notion that the differential activation of
Notch signaling by the Numb proteins is mediated at the level
of post-endosomal sorting of the Notch receptor (48).
Notch Signaling Modulates TRPC6 Expression in a Manner
Dependent on the PTB Domain of Numb—We previously
reported that Numbmodulates intracellular Ca2 homeostasis
in a manner dependent on the PTB
domain (16, 30). Because destabili-
zation of intracellular Ca2 homeo-
stasis was a critical component of
the cell death-promoting effect of
the SPTB-Numb proteins (16, 30),
we next determined whether the
PTB domain-specific effect of the
Numb proteins on Ca2 homeosta-
sismay bemediated through the dif-
ferential activation of the Notch
pathway. First, we determined
whether Notch signaling may regu-
late the expression of Ca2 regula-
tory protein(s) that are important
for Ca2 signaling during differenti-
ation, proliferation, migration, and
cell death. We previously showed
that PC12-SPTB-Numb exhibited a
dramatically greater Ca2 response
to carbachol and bradykinin (16,
30), two agonists that not only
induce Ca2 release in PC12 cells
but also stimulate Ca2 entry across
the plasma membrane through
SOCs and ROCs. Because members
of the TRPC family have been pos-
tulated as candidates for forming
both SOCs and ROCs, wemeasured
the expression of TRPC transcripts
in PC12-Numb clones by qRT-PCR
using primer sets listed in Table 1.
PC12 cells express most of the
TRPC (TRPC1–7) members except
for TRPC2 and TRPC7 (50). Levels
of TRPC3 and TRPC6 transcripts
FIGURE 3. Numb alters the endocytic trafficking of Notch in an isoform-specific manner. A, -secretase
activity in the PC12 clones stably overexpressing the indicated Numb isoforms that differ in the PTB domain.
The values are themeans S.E. of three independent experiments. *, p 0.05 (ANOVAwith Scheffe post-hoc
tests). B, steady-state level of Notch1 and Jagged1 transcripts in the indicated PC12 clones. The level of these
transcripts was determined in triplicate by real-time PCR and normalized to the expression of the housekeep-
ing gene 18S. The values are the means  S.E. of three independent experiments. *, p  0.05 (ANOVA with
Scheffe post-hoc tests) compared with vector-transfected (VT) clones. The corresponding proteins are shown
in the inset. C, representative confocal micrographs showing the localization of Notch1 to Rab5a-labeled
endocytic compartments in the indicated PC12 clones. Following fixation and permeabilization, rabbit anti-
Rab5a and goat anti-rabbit CY3-conjugated secondary antibody were used to label the endocytic compart-
ments (red signal), and goat anti-Notch1 (raised to the N-terminal extracellular domain) and goat anti-goat-
fluorescein isothiocyanate-conjugated secondaryantibody todetectNotch1protein (green signal). Thebottom
images show the merged images of Notch and Rab5a, depicting co-localization of Notch1 with early endo-
somes. The images are representative of those obtained from at least two stably transfected clonal cell lines.
TABLE 1
Oligonucleotide sequences of TRPC primers used for real-time RT-PCR
Target GenBankTM accession no. Orientation Sequence (5–3) Predicted size Nucleotide location
bp
TRPC1 AF061266 Forward CGACACCTTCCACTCGTTCA 64 1716–1780
Reverse GCGCTAAGGAGAAGATGTACCAGA
TRPC2 NM017011 Forward GTTCCAGTTTCTCTTCTGGACCAT 190 1804–1994
Reverse CAGCATCGTCCTCGATCTTCT
TRPC3 AB022331 Forward CATGCAGTGCAAAGACTTCGTAG 74 531–605
Reverse TTCAGAATGGCTTCCACCTCTT
TRPC4 NM_080396 Forward CTCTGCAGATATCTCTGGGAAGAAT 67 1514–1581
Reverse CACGAGGCAGTATATGAATAAGAACTTT
TRPC5 AY064411 Forward TGAAACCCTTCAGTCACTCTTCTG 102 2038–2140
Reverse AGTAGCTCCCACAAACTCCGTG
TRPC6 NM_053559 Forward AGTGTACAGAATGCAGCCAGAAAC 79 758–837
Reverse CAGCCCTTTGTAGGCATTGATC
TRPC7 XM_225159 Forward CCCTTTAACCTGGTGCCGA 113 2665–2778
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were markedly increased in PC12-SPTB-Numb when com-
pared with PC12-VT and PC12-LPTB-Numb (supplemental
Fig. S3). Although TRPC1 is the most abundant transcript, no
significant change in the level of the corresponding protein was
detected among the PC12 clones. By contrast, TRPC4, TRPC5,
and TRPC7 proteins are expressed at very low or undetectable
level in PC12 cells (data not shown (50)).
To examine the corresponding changes in TRPC3 and
TRPC6 protein levels, we performed immunostaining and
immunoblotting (Fig. 4A). Whereas TRPC1 protein was not
markedly different among the PC12 clones, levels of TRPC3
and TRPC6 protein were significantly elevated only in PC12-
SPTB-Numb cells by 2- and 10-folds, respectively (Fig.
4A).
Pharmacological inhibition of the Notch pathway in PC12-
SPTB-Numb by using DAPT resulted in markedly lower levels
of TRCP6 transcript (Fig. 4B) and protein (Fig. 4C) but had little
impact on TRPC3 expression. TRPC1 protein level was not
altered in the presence of DAPT (Fig. 4C). Treatment with a
-secretase inhibitor, which is known to inhibit the processing
of the amyloid precursor protein but not the Notch receptor,
had nomeasurable effect on either TRPC6 or TRPC3 transcript
level in PC12-SPTB-Numb (Fig. 4D). The latter indicates that
the Numb-isoform-specific effects on TRPC6 expression are
not caused by altered APP processing (31). Collectively, these
data suggest that the PTB domain-specific regulation of the
Notch pathway is correlated with subtype-specific expression
of TRPC.
Notch-mediated Expression of TRPC6 Augments ROCE—To
determine whether Notch-induced expression of TRPC6 dif-
ferentially impacts Ca2 entry in PC12 cells, we applied OAG
(100 M), the membrane permeant analogue of diacylglycerol,
which induces Ca2 entry through receptor-operated TRPC3,
-6, and -7 (51, 52). Unlike carbachol, OAG activates SOCswith-
out causing ER Ca2 release that may in turn activate SOCE.
PC12-SPTB-Numb exhibited slightly higher resting [Ca2]i
level comparedwith PC12-LPTB-Numb, but this difference did
not reach statistical significance (Fig. 5, A and B). The magni-
tude of the OAG-evoked Ca2 transients were significantly
greater in PC12-SPTB-Numb when compared with PC12-
LPTB-Numb and PC12-VT (Fig. 5,A andB) suggesting that the
expressedTPRCproteins assembled into functional ROCs. The
OAG-evoked Ca2 transients were not observed when the cells
were bathed in a Ca2-free medium (data not shown). Further-
more, the OAG-induced Ca2 responses were unaffected by
the L-type voltage-dependent Ca2 channel blocker nifedipine
(Fig. 5B), but they were strongly inhibited by SKF-96365 (Fig.
5B), a commonly used blocker of TRPCs (53).
To verify that TRPC6 was mainly responsible for the OAG-
induced Ca2 transients in PC12-SPTB-Numb, we selectively
FIGURE 4. Numbmodulates subtype-specific TRPC expression in an isoform-dependent manner via the Notch signaling pathway. A, levels of TRPC1,
TRPC3, and TRPC6 protein in the indicated PC12 clones were assessed by immunoblotting (left panels) and immunostaining (right panels). Cultures were fixed
and stainedwith antibodies to TRPC3 and TRPC6. B andC, effects of DAPT (20M) on the levels of TRPC6 and TRPC3 transcripts (B) andproteins (C). The amount
of each transcript was determined in triplicate by real-time PCR and normalized to the expression of the housekeeping gene 18S. *, p  0.05 (ANOVA with
Scheffe post-hoc tests) compared with vehicle (Veh)-treated cultures. Protein amount was determined by immunoblotting using antibodies to TRPC3 and
TRPC6. Equal protein loading was confirmed by reprobing the blots with an antibody to actin. The histogram shows the density of TRPC6 protein band
normalized to actin. The values are the means  S.E. of three independent experiments. *, p  0.05 (ANOVA with Scheffe post-hoc tests) compared with
Veh-treated cultures.D, effects of-secretase inhibitor II (BACE Inh., 10M) on the expression of TRPC6 and TRPC3. The level of each transcript was quantitated
by real-time RT-PCR and normalized to the expression of the housekeeping gene 18S. The values are the means S.E. of three independent experiments.
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knocked down TRPC6 expression by RNA interference. qRT-
PCR analysis was utilized to assess the efficiency of suppression
of TRPC6 expression and to evaluate whether the siRNA con-
struct had any cross-reactivity in terms of suppressing non-
targeted TRPC homologs. Transfection of PC12-SPTB-Numb
with siRNA-TRPC6 but not siRNA-Con substantially sup-
pressed levels of TRPC6 transcript (Fig. 5C). Knockdown of
TRPC6 did not alter the expression of all other TRPC mRNAs
(data not shown). The efficiency of suppression of TRPC6 pro-
tein was confirmed by immunostaining (supplemental Fig. S4)
and immunoblotting (Fig. 5C) and was in the range between 60
and 70% (Fig. 5C). Although TRPC6 knockdown in PC12-
SPTB-Numb failed to abrogate OAG-stimulated Ca2 entry,
the OAG-dependent increase of [Ca2]i was substantially
reduced in the presence of siRNA-TRPC6 (Fig. 5D). Hence,
despite TRPC6 knockdown, the OAG-stimulated receptor-op-
erated Ca2 entry (ROCE) activity remained higher in PC12-
SPTB-Numbcomparedwith PC12-LPTB-NumbandPC12-VT
cells (Fig. 5D), and this may be attributed to the differential
expression of TRPC3 (Fig. 4A), which is known to assemble
into homomeric ROCs (51, 52). The OAG-stimulated ROCE
was slightly but not significantly decreased in PC12-VT and
PC12-LPTB-Numb (Fig. 5D), and this may be attributable to
siRNA-TRPC6-mediated reduction of basal TRPC6 protein
level. Consistent with the notion that Notch signaling mod-
ulates TRPC6-mediated ROCE, we found that pretreatment
with DAPT at a dose that inhibited TRPC6 expression (Fig.
4C) markedly inhibited OAG- evoked Ca2 transients in
PC12-SPTB-Numb (supplemental Fig. S5A).
Notch-mediated Expression of TRPC6 Augments SOCE—Al-
though TRPC6 overexpression studies uniformly support the
formation of ROCs (51, 52), several recent studies suggest a role
for TRPC6 in forming native SOCs (54, 55). To test whether the
Notch-mediated up-regulation of TRPC6 also enhances SOCE
activity, we used the Ca2 add-back assay previously validated
to activate store-operated Ca2 entry (SOCE) (33). Cultures of
PC12 cells were perfused with the irreversible sarco(endo)plas-
mic reticulum pump inhibitor TG in Ca2-free medium con-
FIGURE 5. Numb modulates intracellular calcium homeostasis in an isoform-specific manner. A, representative recordings showing the mean [Ca2]i
before and after the addition of OAG in the indicated PC12 clones. Cells were loaded with fura-2, and [Ca2]iwas recorded as described under “Experimental
Procedures.” Thearrow indicates timeof additionofOAG (100M).B, effect of SKF96365 (50M) andnifedipine (5M)onbasal [Ca2]i and thepeak [Ca
2]i after
exposure to OAG. Ca2measurements are shown as F340/F380 ratios obtained from four separate cultures (30–50 cells assessed/culture); *, p 0.01 compared
with PC12-SPTB-Numb.C, siRNA-mediated knockdownof TRPC6 reduces transcript andprotein levels. PC12-SPTB-Numbwere transfectedwith siRNA (100 nM)
targeting TRPC6 (siRNA-TRPC6) or non-silencing control siRNA (siRNA-Con) for 24 h. The level of TRPC6 transcript was determined in triplicate by real-time PCR
and normalized to the expression of housekeeping gene 18S. The values are the means S.E. of three independent experiments. *, p 0.05 (ANOVA with
Scheffe post-hoc tests) comparedwith cultures transfectedwith siRNA-Con.D, effect of TRPC6 knockdown on theOAG-induced peak of [Ca2]i. The indicated
PC12cloneswere transfectedwitheither siRNA-TRPC6or siRNA-Con (100nM) for 24hand theOAG-induced increase in [Ca2]iwas recordedasdescribedunder
“Experimental Procedures.” Ca2measurements are shown as F340/F380 ratios obtained from four separate cultures (30–50 cells assessed/culture); *, p 0.01;
#, p 0.05 compared with PC12-SPTB-Numb. E, representative recordings showing themean [Ca2]i after the sequential addition of 1M thapsigargin and 2
mM Ca2 in the perfusate containing 5 M nifedipine. The indicated PC12 clones were incubated in Ca2 free KRB buffer and the change in [Ca2]i upon the
addition of thapsigargin and Ca2was recorded as described under “Experimental Procedures.” F, the peak increase of [Ca2]i after exposure to thapsigargin
and re-addition of Ca2 in the indicated clones of PC12 cells. Ca2measurements are shown as F340/F380 ratios obtained from four separate cultures (30–50
cells assessed/culture); *, p 0.01; #, p 0.05 compared with PC12-SPTB-Numb.
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tainingnifedipinetopreventCa2entry throughL-typevoltage-
dependent Ca2 channels and EGTA to chelate any residual
Ca2 (33). In the absence of external Ca2, TG-dependent inhi-
bition of Ca2 sequestration elevated [Ca2]i due to passive
release of Ca2 from the ER. The TG-induced elevation of
[Ca2]iwas significantly higher in PC12-SPTB-Numb (Fig. 5, E
and F) suggesting that expression of the Numb proteins differ-
entially modulates refilling of the ER Ca2 store. Following the
return of Ca2 to basal level, Ca2 was re-added into the
medium to a final concentration of 2.0 mM, and SOCE was
evaluated by the increase in [Ca2]i, reflecting Ca2 entry into
the cytoplasm (Fig. 5E). The initial peak of the increase in
[Ca2]i (increase in fluorescence ratio/min) observed upon the
admission of external Ca2 was significantly greater in PC12-
SPTB-Numbcomparedwith PC12-VTandPC12-LPTB-Numb
(Fig. 5F). Because the activation of SOCs depends on the filling
state of the stores, we next determined whether TGwas equally
depleting inositol 1,4,5-trisphosphate-sensitive stores in the
clones examined. Addition of carbachol following TG treat-
ment had no additional effect on Ca2 release in all clones sug-
gesting that TG had completely emptied intracellular stores
(data not shown). To verify that the response to Ca2 re-addi-
tion reflected Ca2 influx, we checked whether Mn2 could
quench the fura-2 fluorescence excited at 360 nm (F360) in
PC12-SPTB-Numb after perfusion
with Ca2-free KRB buffer contain-
ing nifedipine. SOCE was evaluated
by measuring the rate at which the
fluorescence intensity at 360 nm
(F360) was quenched by Mn2, a
Ca2 surrogate that enters the cells,
and reduces fluorescence upon
binding to the dye (34). Rates of
Mn2 inflow (decrease in fluores-
cence units/min) following addition
of cyclopiazonic acid, a revers-
ible sarco(endo)plasmic reticulum
pump inhibitor, were significantly
reduced in the presence of siRNA-
TRPC6, suggesting thatMn2 entry
through SOCs was dependent
on TRPC6 (supplemental Fig. S6).
Treatment with DAPT at the dose
that markedly inhibited TRPC6
expression (Fig. 4C) resulted in a
significant inhibition of SOCE in
PC12-SPTB-Numb cells (supple-
mental Fig. S5B), suggesting that
Notch modulation of TRPC6 ex-
pression could also impact SOCE
activity. Because TRPC3 expres-
sion is not affected by DAPT (Fig.
4D), the residual SOCE activity
detected PC12-SPTB-Numb cells
following DAPT treatment (sup-
plemental Fig. S5B) could be
attributed to TRPC3, because this
TRPC is capable of combining
with TRPC1 and TRPC7 to form native SOCs (56).
Stress-induced Expression of TRPC6 Is Sensitive to Notch
Pathway Modulation—Having shown that overexpression of
the Numb proteins in PC12 cells differentially modulates cellu-
lar Ca2 homeostasis via Notch-dependent induction of
TRPC6 expression, we next examined whether the stress-in-
duced switch of Numb isoforms (Fig. 1) was sufficient to up-
regulate TRPC6 expression in a manner dependent on activa-
tion of the Notch pathway. Increased Notch receptor
localization to early endosomes was detected prior to accumu-
lation of NICD in the nucleus of naïve PC12 cells subjected to
TFW (supplemental Fig. S7). Real-time PCR, immunoblotting,
and immunolabeling experiments confirmed the TFW-in-
duced increase of TRPC6mRNA and protein in PC12 (Fig. 6A).
BothTRPC6 transcript andproteinwere significantly increased
after TFW. By contrast, expression of TRPC3 was not substan-
tially altered after TFW (Fig. 6B). The Notch-induced TRPC6
expression in PC12 cells following TFWwas associated with an
increase in steady-state [Ca2]i (Fig. 6C). Treatment with
siRNA-TRPC6 but not siRNA-Conmarkedly attenuated TFW-
induced elevation of [Ca2]i in PC12 cells 16 h after TFW
(Fig. 6C).
To establish that TFW-induced TRPC6 expression requires
activation of the Notch pathway, PC12 cells were treated with
FIGURE 6. TFW-induced activation of the Notch pathway is sufficient to increase TRPC6-mediated Ca2
entry. A, time course of TRPC6 transcript and protein levels in cultures of PC12 cells subjected to TFW. The
amount of transcriptwas determined in triplicate by real-time PCR and normalized to the expression of house-
keeping gene 18S (left panel). Protein amount was determined by immunoblotting (center panel) and immu-
nostaining (right panel). The increase of TRPC6 protein is shown in the inset. The values are themeans S.E. of
three independent experiments. *, p  0.05 (ANOVA with Scheffe post-hoc tests) compared with untreated
cultures. B, time course of TRPC3 transcript in cultures of PC12 cells subjected to TFW was determined as
described in A. C, cultures of PC12 cells were incubated with siRNA-TRPC6 or siRNA-Con (100 nM) for 24 h prior
to TFW. Cells were then loaded with fura-2, and steady-state [Ca2]i was recorded as described under “Exper-
imental Procedures.” Ca2measurements are shown as F340/F380 ratios obtained from four separate cultures
(30–50 cells assessed/culture); *, p 0.05 compared with untreated and TFW-treated cultures incubated with
siRNA-TRPC6.D, cultures of PC12 cellswere incubatedwith 20MDAPT () or vehicle () for 24 hprior to TFW.
At 12h followingTFW, levels of TRPC6andactin in cell lysatesweredeterminedby immunoblotting. The values
are the means  S.E. of three independent experiments. *, p  0.05 (ANOVA with Scheffe post-hoc tests)
compared with untreated cultures and TFW-treated cultures incubated with DAPT. E, cultures of PC12 cells
were incubated with 20 M DAPT () or vehicle () for 24 h prior to TFW. At 12 h following TFW, levels of the
SPTB- and LPTB-Numb transcriptsweredetermined in triplicate by real-timePCR, normalized to the expression
of housekeeping gene 18S, and expressed in -fold change relative to the non-treated cultures. The values are
the means S.E. of three independent experiments. *, p 0.05 (ANOVA with Scheffe post-hoc tests).
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DAPT for 2 h prior toTFW.We found that incubation ofDAPT
at concentrations that significantly blocked TFW-induced
Notch activation (Fig. 1C) robustly reduced both transcript and
protein level of TRPC6 in PC12 cells after TFW (Fig. 6D).
DAPT did not prevent the TFW-induced switch in Numb iso-
forms (Fig. 6E) further confirming the notion that this switch is
an early event (Fig. 2) that precedes Notch activation and,
hence, is independent of Notch activation. Treatment of PC12
cells with siRNA-Notch1 (supplemental Fig. S8A) and DAPT
(supplemental Fig. S8B) replicated the results obtained with
siRNA-TRPC6 (Fig. 6C) further confirming that TFW-induced
Notch signaling mediates Ca2 entry through TRPC6.
Next, we treated PC12 cells with the Jagged1 peptide ligand
to activate Notch signaling (36). The Jagged1 peptide increased
the level of Hes-1 transcript confirming activation of the Notch
pathway (Fig. 7A). Concomitantly, the Jagged1 peptide
increased TRPC6 but not TRCP3 transcripts in PC12 cells (Fig.
7B). Similar toDAPT (Fig. 6E), treatment with the Jagged1 pep-
tide alone did not induce a switch of Numb isoforms (Fig. 7C).
Expression of TRPC6 Increases Cellular Vulnerability to TFW
via Activation of Calcineurin—Next we investigated the func-
tional implications of Notch-induced TRPC6 expression. Pre-
vious reports suggest a cross-talk of the Notch pathway with
calcineurin (57), also known as protein phosphatase 2B (58).
Calcineurin is activated by sustained increases in [Ca2]i and,
therefore, serves to couple intracellular Ca2 to the dephos-
phorylation of selected substrates such as nuclear factor of acti-
vated T cells (58, 59). Calcineurin and FKBP12, the 12-kDa
FK506-binding protein, have been shown to form a functional
multiprotein complex with TRPC6 (60). To determine whether
TFW-induced TRPC6 expression is
linked to the activation of the cal-
cineurin pathway, we measured cal-
cineurin activity in PC12 cells. TFW
markedly increased calcineurin
activity (Fig. 8A), which was
reversed by knocking down TRPC6
(Fig. 8B). Prior studies indicated
that a high level of calcineurin activ-
ity may render neuronal cells sus-
ceptible to serum deprivation-in-
duced apoptosis, which was
prevented by Bcl-2 overexpression
or incubation with cyclosporin A or
FK506 (61). FK506 is an immuno-
suppressant that directly binds to
FKBP12 and inhibits formation of
complexes with TRPC6 (60). Treat-
ment with FK506 significantly
ameliorated TFW-induced activa-
tion of calcineurin (Fig. 8A) and
protected PC12 cells from TFW-
induced death (Fig. 8C). Similarly
to FK506, TRPC6 knockdown
markedly decreased TFW-in-
duced cell death (Fig. 8D) further
establishing that TRPC6 up-regu-
lation is a required step for the
Ca2 dependence of calcineurin activation.
Expression of LPTB-NumbDecreases Neuronal Vulnerability
to TFW—Because LPTB-Numb exerted opposite action com-
pared with SPTB-Numb, we next determined the role of LPTB-
Numb in TFW-induced Notch activation and cell death.
Immunoblotting showed that TFW-induced Notch activation
is significantly attenuated in PC12-LPTB-Numb compared
with PC12-VT (Figs. 9, A and B). PC12-LPTB-Numb were also
more resistant to TFW-induced death when compared with
PC12-VT (Fig. 9C).
DISCUSSION
Beyond their role in stem cell maintenance, Notch and
Numb are also essential in the formation of neuronal cell shape
and synaptic connection in the developing brain (62, 63).
Increased Notch activity was associated with decreased neurite
outgrowth, and this effect was reversed by expression of Numb
(62). Although both Notch and Numb remain to be expressed
in adult tissues, including the brain (64), little is yet known
about their interaction and functional roles.
Deficiency of the Notch pathway resulted in specific neuro-
cognitive deficits related to long term memory formation in
Drosophila melanogaster and mice (65, 66). A link between
Notch and memory deficits is suggested by data showing that
the presenilin protein required for proteolytic cleavage of
NICD fromNotch is mutated in familial Alzheimer disease (45,
46). Recent studies also implicate aberrant Notch signaling in
stroke (36), cancers (9, 10), and diabetic nephropathy (67).
IncreasedNotch activation is associated with dendritic atrophy
FIGURE7.Directactivationof theNotchpathway increasesTRPC6expression.AandB, timecourseofHes1,
TRPC6, andTRPC3 transcripts in cultures of PC12 cells thatwere treatedwith Jagged1or a scramblepeptide (15
M). The amount of each transcript was determined in triplicate by real-time RT-PCR and normalized to the
expression of housekeeping gene 18S. The values are the means S.E. of three independent experiments. *,
p 0.01 (ANOVA with Scheffe post-hoc tests) compared with untreated cultures. C, time course of the SPTB-
and LPTB-Numb transcripts in cultures of PC12 cells thatwere treatedwith either Jagged1or scramble peptide
(15 M). Transcript levels were determined in triplicate by real-time PCR. The amount of each transcript was
normalized to the expression of housekeeping gene 18S and expressed in -fold change relative the scramble
peptide-treated cultures.
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in prion-infected brains of mice (68). Hence, the Notch signal-
ing pathway is tightly regulated both temporally and spatially.
Several HECT-domain E3 ubiquitin-ligases regulate the
number and availability ofNotch receptors at the cell surface by
ubiquitinylating and targeting Notch for degradation (47). The
potency of Notch signaling also depends on intrinsic regulators
that positively or negatively influence the strength and duration
of the Notch signal. Numb is a critical negative regulator of
Notch, and Numb deficiency affects the same developmental
steps that are physiologically regulated by the Notch pathway.
Numb is an endocytic adapter involved in the internalization
and recycling of cell surface proteins (42) suggesting thatNumb
likely influencesNotch signaling activity through vesicular traf-
ficking. In the D. melanogaster nervous system, Numb triggers
the endocytosis of Sanpodo, a positive regulator of Notch, tar-
geting it to the late endosomes (69).
The role of Numb in regulating Notch activity in vertebrates
is less clear. Recent studies showed that endosomal entry is
required for Notch activation (70) and that post-endosomal
sorting of the Notch receptor plays a role in signal modulation
(71). We previously reported that the Numb proteins regulate
the post-endosomal sorting of APP (31). This trafficking func-
tion of Numb appears to be important in the regulation of APP
proteolytic processing and the generation of amyloid-peptide
(A), the principle component of senile plaques in Alzheimer
disease. Numb proteins that differ in the PTB domain have
opposite effects on the endosomal sorting and processing fate
of APP (31). Expression of SPTB-Numb isoforms results in the
retention of APP and C-terminal APP fragments (APP-CTFs)
within the early endosomes, which in turn favors the produc-
tion of A locally by -secretase. In contrast, expression of
LPTB-Numb isoforms reduces the dwelling time of APP in the
early endosomes and increases lysosome-mediated turnover of
APP, resulting in a substantial reduction in the cellular content
of APP and APP-CTFs (31). Collectively, our data suggest that
Numb influences post-endocytic sorting and processing fates
of APP in a manner dependent on the PTB-domain. Although
the detailed molecular mechanism of Numb-mediated post-
endocytic trafficking is not known, the insertion in the PTB
domain of Numb may induce structural elements that are suf-
ficient to mediate APP recycling and to strongly inhibit post-
endocytic degradation.
In the present study we found that the Numb proteins also
have disparate consequences forNotch activation by regulating
intracellular trafficking of the Notch receptor. By evaluating
Notch localization in the various endocytic compartments, we
uncovered that, similarly to APP (31), the degree of Notch co-
localizationwith the Rab5-labeled early endosomes is greater in
PC12 clones expressing SPTB-Numb compared with those
clones expressing LPTB-Numb (Fig. 3C). Notch pathway activ-
ity was also robust in clones expressing SPTB-Numb as evident
by the elevated steady-state levels ofNICDprotein (Fig. 2A) and
Hes-1 transcript (Fig. 2B), suggesting that Notch retention in
the early endosomes promotes -secretase cleavage. These
findings are consistent with a previous report showing that
-secretase cleavage of Notch is reduced in D. melanogaster
mutants that impair endosomal entry but is enhanced in
mutants that increase endosomal retention (70).
Although basal Notch signaling activity in PC12-LPTB-
Numb was slightly but not significantly lower compared with
PC12-VT (Fig. 2A), the TFW-induced Notch activation was
markedly attenuated in PC12-LPTB-Numb compared with
PC12-VT (Fig. 9A). It remains to be determined how the LPTB-
Numb isoforms suppress TFW-induced Notch activation.
LPTB-Numb isoforms may promote the trafficking of the
Notch receptor to the degradative pathway because Notch has
been shown to be degraded in the lysosomes (71, 72). It is also
worth noting that the PTB insertion is required for the recruit-
ment of the HECT-type E3 ligase Itch and for targeting Notch
for Itch-dependent ubiquitination and proteasomal degrada-
tion (47, 71, 73). Collectively, these data suggest that the Numb
proteins differentially influence the endocytic activation of
Notchwithout altering the expression of the components of the
Notch pathway.
Several lines of evidence imply that the Numb isoforms have
distinct cellular functions (13, 14). Ectopic expression of Numb
isoforms without the insertion in the PRR promotes differenti-
ation, whereas those isoforms with the insertion direct the pro-
FIGURE 8. TFW-induced cell death is dependent on TRPC6-mediated acti-
vation of calcineurin. A, time course of calcineurin activity in cultures of
PC12 cells that were treated with FK506 (1 M) 1 h prior to TFW. At the indi-
cated time points following TFW, calcineurin activity in cell lysates was mea-
sured by a colorimetric assay using the RII phosphopeptide as substrate. Val-
ues are shown as arbitrary units and are the means  S.E. of three
independent experiments performed in duplicate. *, p  0.05 (ANOVA with
Scheffe post-hoc tests) compared with the indicated cultures. B, time course
of calcineurin activity in cultures of PC12 cells that were treated with siRNA-
Con and siRNA-TRPC6 (100 nM) for 18 h prior to TFW. The values are the
means  S.E. of three independent experiments performed in duplicate. *,
p 0.05 (ANOVA with Scheffe post-hoc tests) compared with the indicated
cultures. C, cultures of PC12 cells were exposed to the calcineurin inhibitor
FK506 (1M) 1 h prior to TFW. Cell viability was determined 24 h after TFWby
Hoechst staining. Forty fields compromising at least 30–50 cells were
counted. Results shown are the means  S.E. of three independent experi-
ments performed in duplicate. *, p  0.05 (ANOVA with Scheffe post-hoc
tests) compared with vehicle-treated cultures. D, cultures of PC12 cells were
exposed to siRNA-Con and siRNA-TRPC6 (100 nM) for 18 h prior to TFW. Cell
viability was determined 24 h after TFW by Hoechst staining. The values are
the means S.E. of three independent experiments performed in duplicate.
*, p 0.01; **, p 0.05 (ANOVA with Scheffe post-hoc tests) compared with
the indicated cultures.
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liferation of neural crest stem cells (13). The Numb proteins
also differentially modulate the responses of PC12 cells to the
neurotrophic factor nerve growth factor, namely, stimulation
of neurite outgrowth and cell survival dependence (31).
Changes in intracellular Ca2 are known to be involved in
key processes during development such as neuronal cell prolif-
eration, differentiation, migration, and cell death (19–21).
Because of the interplay between Numb and Notch in various
cellular processes important for development, it is tempting to
speculate that Notch and Numb modulate these diverse pro-
cesses, in part, bymodifyingCa2-sensitive signaling pathways.
We previously reported that the Numb proteins alter intracel-
lular Ca2 homeostasis in a manner dependent on the PTB
domain and that destabilization of intracellular Ca2 homeo-
stasis is a critical component of the cell death-promoting effect
of SPTB-Numb (16). It is not known how the Numb proteins
impact the Ca2 homeostatic mechanisms that influence neu-
ronal life/death cell fate decisions. In this study, we examined
whether alterations in cellular Ca2 homeostasis may be the
direct consequence of the differential modulation of the Notch
pathway by theNumb proteins.We found that activation of the
Notch pathway is required for the expression of TRPC6 and
that the Numb proteins differentially modulate TRPC6 expres-
sion by altering the signaling strength of the Notch pathway
(Figs. 3 and 4, A–C).
The Notch-induced TRPC6 expression in PC12-SPTB-
Numb clones was accompanied by heightened OAG-induced
SKF96365-sensitive Ca2 transients suggesting that the ex-
pressed TRPC6 functionally augmented Ca2 entry (Fig. 5, A
and B). Increased TRPC6 expression in PC12-SPTB-Numb
clones also augmented SOCE in
response to TG-induced store
depletion (Fig. 5, E and F). Knock-
down of TRPC6 markedly reduced
both OAG- and TG-stimulated
Ca2 entry indicating that TRPC6
was mainly responsible for en-
hanced Ca2 entry through ROCs
(Fig. 5, A and B) and SOCs (Fig. 5, E
and F). Pretreatment with DAPT
also markedly inhibited the OAG-
and TG-stimulated Ca2 entry
(supplemental Fig. S5) consistent
with the notion thatNotch signaling
mediates TRPC6-dependent Ca2
entry.
The secretase activities involved
in Notch processing are also
involved in APP processing. As
reported previously, the Numb pro-
teins differentially modulate APP
processing leading to the accumula-
tion of APP derivatives in PC12-
SPTB-Numb but not PC12-LPTB-
Numb (31). BothA andAPP-CTFs
can alter cellular Ca2 homeostasis
(74). The -secretase-dependent
proteolytic release of the intracellu-
lar domain of APP and its subsequent translocation to the
nucleus suggest that it plays a signaling role analogous to NICD
(75). A functional role for the intracellular domain of APP in
regulating phosphoinositide-mediated Ca2 signaling has been
reported (76). To exclude the possibility that the effects of the
Numb proteins on cellular Ca2 homeostasis weremediated by
either intracellular domain of APP or A, we treated PC12 cells
with a -secretase inhibitor that blocks the production of these
APP derivatives (31). Treatment of PC12-SPTB-Numb with
-secretase inhibitor had no impact on TRPC6 expression in
PC12-SPTB-Numb (Fig. 4D) thus excluding a direct role of
these derivatives of APP proteolysis in the observedTRPC6-de-
pendent changes in cellular Ca2 signaling and homeostasis.
Despite their similarity in amino acid sequence, members of
the TRPC subfamily have differentmodes of activation (25, 26).
There is still considerable controversy regarding which TRPC
proteins form native SOCs or ROCs. Although TRPC6 overex-
pression studies uniformly support the formation of ROCs, sev-
eral recent studies suggest a role for TRPC6 in forming native
SOCs (54–56). Considering that TRPCs probably function as
tetramers, overexpression may result in a predominance of
homotetrameric structures, whereas endogenous expression
may reflect heteromers between TRPC channel subtypes (25).
TRPC6 may form a functional heteromeric complex with
TRPC3, which has been implicated as a ROC and SOC (50).
Our data are consistent with the notion that Notch-depen-
dent up-regulation of endogenous TRPC6 can enhance both
ROC and SOC function (Fig. 5).While endogenous TRPC6 can
elicit a SOCE event in certain cell types under specific condi-
tions, it is also likely that Notch may regulate the expression of
FIGURE 9. Expression of LPTB-Numb ameliorates TFW-induced Notch activation and cell death. A, repre-
sentative immunoblots showing the timecourseofNICDprotein level inPC12-VTandPC12-LPTB-Numbclones
after TFW. B, the histogram shows the density of the NICD protein band normalized to actin. The values are the
means S.E. of three independent experiments. *, p 0.05 (ANOVA with Scheffe post-hoc tests) compared
with cultures at the indicated time points. C, time course of the TFW-induced cell death in PC12-VT and
PC12-LPTB-Numb clones. Cell viability was determined 16 h after TFW by Hoechst staining. Forty fields com-
promising at least 60 cells were counted. The values are themeans S.E. of three independent experiments. *,
p 0.05 (ANOVA with Scheffe post-hoc tests) compared with PC12-VT.
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additional components required to generate a properly regu-
lated and store-operated TRPC6. We cannot rule out the pos-
sibility that increased TRPC6-mediated Ca2 entry could be in
part attributed to changes in the physicochemical characteris-
tics of this channel. These interesting possibilities warrant
future investigations.
Both SOCs and ROCs are present in non-excitable and excit-
able cells such as cardiac and skeletal muscle cells (77) and
neurons (78). SOCE may be critical for neuronal migration
and neurite outgrowth during cortical development (79) and
for synaptic plasticity in the adult brain (80). Each of these
processes has been shown to be impacted by altered Numb
(31, 43, 44) or Notch function (63, 66), although it is yet not
clear how the Numb and Notch interaction influences the
downstream signaling mechanisms that regulate these
processes.
Calcineurin is a highly conserved serine-threonine protein
phosphatase that is present in all tissues in mammals, with
notably high levels in brain where it may account for 1% of the
total protein (58). Activation of the calcineurin signaling path-
way is important in axonal growth and guidance during brain
development and in the regulation of synaptic plasticity (81).
We found that Notch activation during TFW resulted in the
up-regulation of TRCP6 that is mainly responsible to the acti-
vation of calcineurin as knockdown of TRPC6 markedly sup-
pressed TFW-induced calcineurin activity (Fig. 8, A and B).
Aberrant activation of calcineurin has been linked to various
pathological conditions, including Alzheimer disease andHun-
tington disease, cardiomyopathy, and stroke (82–84). Deregu-
lated calcineurin activity is implicated in A-mediated inhibi-
tion of long term potentiation (77) and can predispose
vulnerable neurons to N-methyl-D-aspartic acid-mediated cell
death (76). We showed that pharmacological inhibition of cal-
cineurin or knockdown of TRPC6 expression significantly
attenuated TFW-induced death (Fig. 8, C and D), although the
underlying mechanism remained to be determined. Previous
studies demonstrated that aberrant calcineurin activation can
prime apoptosis by transcriptional-dependent and -indepen-
dent mechanisms (85, 86).
Collectively, these findings suggest that the effects of Numb
and Notch proteins on cell fate decisions are likely mediated by
TRPC6-mediated enhancement of SOC and ROC entries lead-
ing to the activation of Ca2-dependent signaling pathways
(Fig. 10).Whether theNotch pathway is responsible for TRPC6
up-regulation in several disease states such as diabetic
nephropathy (66), focal segmental glomerulosclerosis (29), and
fatal cardiomyopathy (27, 28) require future investigations.
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FIGURE 10. A schematic diagram summarizing the isoform-specific effects of the Numb proteins on the activation of the Notch pathway and the
regulation of cellular Ca2-regulating systems in PC12 cells under stress conditions. In addition to activation of the Notch pathway, trophic factor
withdrawal-induced stress promotes an early switch in the expression of the alternatively spliced Numb isoforms that differentially modulate Notch signaling
strength. Whereas the LPTB-Numb isoforms reduce the dwelling time of the internalized Notch in Rab5-labeled early endosomes, the SPTB-Numb proteins
increase the retention of Notch and its processing to NICD in these endocytic compartments. Consequently, the stress-induced accumulation of Numb-SPTB
promotesNICD-dependent transcriptionof TRPC6,which assembles intonative ROCs andSOCson theplasmamembrane. IncreasedCa2 entry through these
channels leads to the subsequent activation of calcineurin in cells expressing the SPTB-Numb isoforms.
Notch Regulates Ca2 Signaling
FEBRUARY 26, 2010•VOLUME 285•NUMBER 9 JOURNAL OF BIOLOGICAL CHEMISTRY 6823
REFERENCES
1. Artavanis-Tsakonas, S., Rand, M. D., and Lake, R. J. (1999) Science 284,
770–776
2. Lai, E. C. (2002) EMBO Rep. 3, 840–845
3. Schroeter, E. H., Kisslinger, J. A., and Kopan, R. (1998) Nature 393,
382–386
4. Furukawa, T., Maruyama, S., Kawaichi, M., and Honjo, T. (1992) Cell 69,
1191–1197
5. Ohtsuka, T., Ishibashi, M., Gradwohl, G., Nakanishi, S., Guillemot, F., and
Kageyama, R. (1999) EMBO J. 18, 2196–2207
6. Iso, T., Kedes, L., and Hamamori, Y. (2003) J. Cell. Physiol. 194,
237–255
7. Schweisguth, F. (2004) Curr. Biol. 14, R129–R138
8. Conlon, R. A., Reaume, A. G., and Rossant, J. (1995) Development 121,
1533–1545
9. Stylianou, S., Clarke, R. B., and Brennan, K. (2006) Cancer Res. 66,
1517–1525
10. Miele, L., Golde, T., and Osborne, B. (2006) Curr. Mol. Med. 6, 905–918
11. Rhyu, M. S., Jan, L. Y., and Jan, Y. N. (1994) Cell 76, 477–491
12. Pece, S., Serresi, M., Santolini, E., Capra, M., Hulleman, E., Galimberti, V.,
Zurrida, S.,Maisonneuve, P., Viale, G., andDi Fiore, P. P. (2004) J. Cell Biol.
167, 215–221
13. Verdi, J. M., Schmandt, R., Bashirullah, A., Jacob, S., Salvino, R., Craig,
C. G., Program, A. E., Lipshitz, H. D., McGlade, C. J. (1996) Curr. Biol. 6,
1134–1145
14. Dho, S. E., French, M. B., Woods, S. A., and McGlade, C. J. (1999) J. Biol.
Chem. 274, 33097–33104
15. Verdi, J. M., Bashirullah, A., Goldhawk, D. E., Kubu, C. J., Jamali, M.,
Meakin, S. O., and Lipshitz, H. D. (1999) Proc. Natl. Acad. Sci. U.S.A. 96,
10472–10476
16. Chan, S. L., Pedersen, W. A., Zhu, H., and Mattson, M. P. (2002) Neuro-
molecular Med. 1, 55–67
17. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel,
R. E. (1992) J. Neurosci. 12, 376–389
18. Mattson, M. P., and Chan, S. L. (2001) J. Mol. Neurosci. 17, 205–224
19. Munaron, L., Antoniotti, S., and Lovisolo, D. (2004) J. Cell Mol. Med. 8,
161–168
20. Mattson, M. P., LaFerla, F. M., Chan, S. L., Leissring, M. A., Shepel, P. N.,
and Geiger, J. D. (2000) Trends Neurosci. 23, 222–229
21. Berridge, M. J., Bootman, M. D., and Roderick, H. L. (2003)Nat. Rev. Mol.
Cell Biol. 4, 517–529
22. Putney, J. W., Jr. (1986) Cell Calcium 7, 1–12
23. Birnbaumer, L., Zhu, X., Jiang, M., Boulay, G., Peyton, M., Vannier, B.,
Brown, D., Platano, D., Sadeghi, H., Stefani, E., and Birnbaumer,M. (1996)
Proc. Natl. Acad. Sci. U.S.A. 93, 15195–15202
24. Boulay, G., Zhu, X., Peyton, M., Jiang, M., Hurst, R., Stefani, E., and Birn-
baumer, L. (1997) J. Biol. Chem. 272, 29672–29680
25. Venkatachalam, K., and Montell, C. (2007) Annu. Rev. Biochem. 76,
387–417
26. Clapham,D. E., Runnels, L.W., and Stru¨bing, C. (2001)Nat. Rev. Neurosci.
2, 387–396
27. Kuwahara, K., Wang, Y., McAnally, J., Richardson, J. A., Bassel-Duby, R.,
Hill, J. A., and Olson, E. N. (2006) J. Clin. Invest. 116, 3114–3126
28. Inoue, R., Jensen, L. J., Shi, J., Morita, H., Nishida, M., Honda, A., and Ito,
Y. (2006) Circ. Res. 99, 119–131
29. Mo¨ller, C. C., Wei, C., Altintas, M. M., Li, J., Greka, A., Ohse, T., Pippin,
J. W., Rastaldi, M. P., Wawersik, S., Schiavi, S., Henger, A., Kretzler, M.,
Shankland, S. J., and Reiser, J. (2007) J. Am. Soc. Nephrol. 18, 29–36
30. Pedersen, W. A., Chan, S. L., Zhu, H., Abdur-Rahman, L. A., Verdi, J. M.,
and Mattson, M. P. (2002) J. Neurochem. 82, 976–986
31. Kyriazis, G. A., Wei, Z., Vandermey, M., Jo, D. G., Xin, O., Mattson, M. P.,
and Chan S. L. (2008) J. Biol. Chem. 283, 25492–25502
32. Chan, S. L., Fu,W., Zhang, P., Cheng, A., Lee, J., Kokame, K., andMattson,
M. P. (2004) J. Biol. Chem. 279, 28733–28743
33. Chan, S. L., Liu, D., Kyriazis, G. A., Bagsiyao, P., Ouyang, X., andMattson,
M. P. (2006) J. Biol. Chem. 281, 37391–37403
34. Wang, J., Shimoda, L. A., and Sylvester, J. T. (2004) Am. J. Physiol. Lung
Cell Mol. Physiol. 286, L848–858
35. Livak, K. J., and Schmittgen, T. D. (2001)Methods 25, 402–408
36. Arumugam, T. V., Chan, S. L., Jo, D. G., Yilmaz, G., Tang, S. C., Cheng, A.,
Gleichmann, M., Okun, E., Dixit, V. D., Chigurupati, S., Mughal, M. R.,
Ouyang, X., Miele, L., Magnus, T., Poosala, S., Granger, D. N., and Matt-
son, M. P. (2006) Nat. Med. 12, 621–623
37. Li, S. C., Zwahlen, C., Vincent, S. J., McGlade, C. J., Kay, L. E., Pawson, T.,
and Forman-Kay, J. D. (1998) Nat. Struct. Biol. 5, 1075–1083
38. Zwahlen, C., Li, S. C., Kay, L. E., Pawson, T., and Forman-Kay, J. D. (2000)
EMBO J. 19, 1505–1515
39. Guo, M., Jan, L. Y., and Jan, Y. N. (1996) Neuron 17, 27–41
40. Spana, E. P., and Doe, C.Q. (1996) Neuron 17, 21–26
41. Lindsell, C. E., Shawber, C. J., Boulter, J., and Weinmaster, G. (1995) Cell
80, 909–917
42. Santolini, E., Puri, C., Salcini, A. E., Gagliani, M. C., Pelicci, P. G., Tac-
chetti, C., and Di Fiore, P. P. (2000) J. Cell Biol. 151, 1345–1352
43. Nishimura, T., and Kaibuchi, K. (2007) Dev. Cell 13, 15–28
44. Wang, Z., Sandford, S.,Wu,C., and Li, S. S. (2009)EMBO J. 28, 2360–2373
45. Kopan, R., and Goate, A. (2000) Genes Dev. 14, 2799–2806
46. Selkoe, D., and Kopan, R. (2003) Annu. Rev. Neurosci. 26, 565–597
47. McGill, M. A., andMcGlade, C. J. (2003) J. Biol. Chem. 278, 23196–23203
48. Jafar-Nejad, H., Norga, K., and Bellen, H. (2002) Dev. Cell 3, 155–156
49. Guo, Q., Sopher, B. L., Furukawa, K., Pham, D. G., Robinson, N., Martin,
G. M., and Mattson, M. P. (1997) J. Neurosci. 17, 4212–4222
50. Tesfai, Y., Brereton. H. M., and Barritt, G. J. (2001) Biochem. J. 358,
717–726
51. Hofmann, T., Obukhov, A. G., Schaefer, M., Harteneck, C., Gudermann,
T., and Schultz, G. (1999) Nature 397, 259–263
52. Dietrich, A., Kalwa, H., Rost, B. R., and Gudermann, T. (2005) Pflugers
Arch. 451, 72–80
53. Merritt, J. E., Armstrong, W. P., Benham, C. D., Hallam, T. J., Jacob, R.,
Jaxa-Chamiec, A., Leigh, B. K., McCarthy, S. A., Moores, K. E., and Rink,
T. J. (1990) Biochem. J. 271, 515–522
54. Liao, Y., Erxleben, C., Yildirim, E., Abramowitz, J., Armstrong, D. L., and
Birnbaumer, L. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 4682–4687
55. Bre´chard, S., Melchior, C., Planc¸on, S., Schenten, V., and Tschirhart, E. J.
(2008) Cell Calcium 44, 492–506
56. Zagranichnaya, T. K.,Wu,X., andVillereal,M. L. (2005) J. Biol. Chem.280,
29559–29569
57. Mammucari, C., Tommasi di Vignano, A., Sharov, A. A., Neilson, J.,
Havrda, M. C., Roop, D. R., Botchkarev, V. A., Crabtree, G. R., and Dotto,
G. P. (2005) Dev Cell. 8, 665–676
58. Rusnak, F., and Mertz, P. (2000) Physiol. Rev. 80, 1483–1521
59. Hogan, P. G., Chen, L., Nardone, J., and Rao, A. (2003) Genes Dev. 17,
2205–2232
60. Kim, J. Y., and Saffen, D. (2005) J. Biol. Chem. 280, 32035–32047
61. Snyder, S. H., Sabatini, D. M., Lai, M. M., Steiner, J. P., Hamilton, G. S.,
Suzdak, P. D. (1998) Trends Pharmacol. Sci. 19, 21–26
62. Sestan, N., Artavanis-Tsakonas, S., and Rakic, P. (1999) Science 286,
741–746
63. Redmond, L., Oh, S. R., Hicks, C., Weinmaster, G., and Ghosh, A. (2000)
Nat. Neurosci. 3, 30–40
64. Roncarati, R., Sestan, N., Scheinfeld, M. H., Berechid, B. E., Lopez, P. A.,
Meucci, O., McGlade, J. C., Rakic, P., and D’Adamio, L. (2002) Proc. Natl.
Acad. Sci. U.S.A. 99, 7102–7107
65. Costa, R. M., Honjo, T., and Silva, A. J. (2003) Curr. Biol. 13, 1348–1354
66. Wang, Y., Chan, S. L., Miele, L., Yao, P. J., Mackes, J., Ingram, D. K.,
Mattson, M. P., and Furukawa, K. (2004) Proc. Natl. Acad. Sci. U.S.A. 101,
9458–9462
67. Niranjan, T., Bielesz, B., Gruenwald, A., Ponda,M. P., Kopp, J. B., Thomas,
D. B., and Susztak, K. (2008) Nat. Med. 14, 290–298
68. Ishikura, N., Clever, J. L., Bouzamondo-Bernstein, E., Samayoa, E.,
Prusiner, S. B., Huang, E. J., and DeArmond, S. J. (2005) Proc. Natl. Acad.
Sci. U.S.A. 102, 886–891
69. Hutterer, A., and Knoblich, J. A. (2005) EMBO Rep. 6, 836–842
70. Vaccari, T., Lu, H., Kanwar, R., Fortini, M. E., and Bilder, D. (2008) J. Cell
Biol. 180, 755–762
71. McGill, M. A., Dho, S. E., Weinmaster, G., and McGlade, C. J. (2009)
Notch Regulates Ca2 Signaling
6824 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 9•FEBRUARY 26, 2010
J. Biol. Chem. 284, 26427–26438
72. Jehn, B. M., Dittert, I., Beyer, S., von der Mark, K., and Bielke, W. (2002)
J. Biol. Chem. 277, 8033–8040
73. DiMarcotullio, L., Ferretti, E., Greco, A., De Smaele, E., Po, A., Sico,M. A.,
Alimandi, M., Giannini, G., Maroder, M., Screpanti, I., and Gulino, A.
(2006) Nat. Cell Biol. 8, 1415–1423
74. Kim, H. S., Park, C. H., Cha, S. H., Lee, J. H., Lee, S., Kim, Y., Rah, J. C.,
Jeong, S. J., and Suh, Y. H. (2000) FASEB J. 14, 1508–1517
75. Cao, X., and Su¨dhof, T. C. (2001) Science 293, 115–120
76. Leissring, M. A., Murphy, M. P., Mead, T. R., Akbari, Y., Sugarman,M. C.,
Jannatipour, M., Anliker, B., Mu¨ller, U., Saftig, P., De Strooper, B., Wolfe,
M. S., Golde, T. E., and LaFerla, F. M. (2002) Proc. Natl. Acad. Sci. U.S.A.
99, 4697–4702
77. Uehara, A., Yasukochi, M., Imanaga, I., Nishi, M., and Takeshima, H.
(2002) Cell Calcium 31, 89–96
78. Tu, P., Kunert-Keil, C., Lucke, S., Brinkmeier, H., and Bouron, A. (2009)
J. Neurochem. 108, 126–138
79. Bouron, A., Altafaj, X., Boisseau, S., and De Waard, M. (2005) Brain Res.
Dev. Brain Res. 159, 64–71
80. Baba, A., Yasui, T., Fujisawa, S., Yamada, R. X., Yamada,M. K., Nishiyama,
N., Matsuki, N., and Ikegaya, Y. (2003) J. Neurosci. 23, 7737–7741
81. Winder, D. G., and Sweatt, J. D. (2001) Nat. Rev. Neurosci. 2, 461–474
82. Xifro´, X., García-Martínez, J. M., Del Toro, D., Alberch, J., and Pe´rez-
Navarro, E. (2008) J. Neurochem. 105, 1596–1612
83. Dineley, K. T., Hogan, D., Zhang, W. R., and Taglialatela, G. (2007) Neu-
robiol. Learn Mem. 88, 217–224
84. Sharkey, J., and Butcher, S. P. (1994) Nature 371, 336–339
85. Latinis, K. M., Norian, L. A., Eliason, S. L., and Koretzky, G. A. (1997)
J. Biol. Chem. 272, 31427–31434
86. Wang, H. G., Pathan, N., Ethell, I. M., Krajewski, S., Yamaguchi, Y., Shi-
basaki, F., McKeon, F., Bobo, T., Franke, T. F., and Reed, J. C. (1999)
Science 284, 339–343
Notch Regulates Ca2 Signaling
FEBRUARY 26, 2010•VOLUME 285•NUMBER 9 JOURNAL OF BIOLOGICAL CHEMISTRY 6825
